Background

While their incidence is on the rise, twin pregnancies are associated with risks to the mothers and their babies. This study aims to investigate the likelihood of adverse neonatal outcomes of twins following assisted reproductive technology (ART) compared to non-ART twins.

Methods

A retrospective population study using the Australian National Perinatal Data Collections (NPDC) which included 19,662 twins of ≥20 weeks gestational age or ≥ 400 g birthweight in Australia. Maternal outcomes and neonatal outcomes (preterm birth, low birth weight, resuscitation and neonatal death) were compared. Generalized Estimating Equations were used to assess the likelihood of any neonatal outcomes, with adjusted odds ratio (AOR) and 95% confidence intervals (CI) presented. Weinberg’s differential rule was used to estimate monozygotic twin rate.

The rate of twin birth has been increased in the past four decades. In the United States, the twin birth rate has increased by 76%; from 1.9% in 1980 to 3.3% in 2009 [1]. In Australia, the rate of multiple deliveries has risen by 15% from 1.3% in 1992 to 1.5% in 2012 [2, 3]. One of the main reasons behind twining rate increase is the introduction of assisted reproductive technology (ART) [4]. The rate of twin birth is high among ART conceived children representing 43% in the US [5] and 6.8% in Australia and New Zealand [6].

Irrespective of the method of conception, twin pregnancies have a greater risk of maternal and neonatal complications compared with singleton pregnancies [7]. When the literature is limited to twins, it is inconsistent with some studies reporting comparable maternal and neonatal outcomes between ART and non-ART twin births [8] while the others have found higher rates of maternal and neonatal complications among ART twin births [4, 9]. There is a lack of national population-based studies in Australia comparing ART and non-ART twins. The aim of this study is to investigate the association of ART on the neonatal outcomes among twins in Australia.

A national population-based retrospective cohort design was used. The data source of this study is the Australian National Perinatal Data Collection (NPDC) from 2007 to 2011. The NPDC includes information on mothers and babies of all live births and stillbirths of at least 20 weeks gestation or at least 400 g birthweight [10]. Data on whether the pregnancy resulted from ART were available for five out of the eight states and territories in Australia (Victoria, Queensland, Western Australia, Tasmania and the Australian Capital Territory) and were included in this study. These five states and territories represented approximately 60% of all births in Australia, with data validation conducted at both state and national levels [10]. The study population included 9831 sets of twin deliveries, with 4580 (23.3%) ART twins and 15,082 (76.7%) non-ART twins.

Maternal characteristics included maternal age at delivery, pre-pregnancy body mass index (BMI), parity, smoking during pregnancy, socioeconomic status, the Indigenous status of the mother, and admitted patient elected accommodation status (public/private). Pre-existing maternal conditions included pre-existing hypertension, and pre-existing diabetes. Pregnancy complications included antepartum haemorrhage, pregnancy-induced hypertension, and gestational diabetes. In NPDU, pregnancy-induced hypertension included both gestational hypertension, and pre-eclampsia [10]. Gestational hypertension is the blood pressure exceeding 140/90 mmHg during pregnancy (after 20 weeks’ gestation) on two readings at least, of more than six hours apart without pre-existing hypertension [11]. Preeclampsia is defined as the presence of hypertension accompanied by proteinuria, utero-placental or organ dysfunctions [11]. Gestational diabetes is the condition where diabetes is first diagnosed during pregnancy and may disappear after giving birth but considered as a risk factor for diabetes occurring in the future [10].

Outcomes at birth included delivery method, preterm birth (gestational age < 37 weeks), stillbirth, low birthweight (birthweight < 2500 g), Apgar score at 5 min, resuscitation at birth, admission to neonatal intensive care unit or special care nursery (NICU/SCN), length of infant stay in hospital in completed day and neonatal death (within 28 days of birth). Among liveborn twins, a combined measure ‘any adverse neonatal outcome’ was created if a birth was preterm, low birthweight, Apgar score at 5 min < 7, required resuscitation, admitted to NICU/SCN or neonatal death. Neonatal death is defined as the death of a live born baby within 28 days of birth [10].

Maternal characteristics, pre-existing maternal conditions, pregnancy complications and neonatal outcomes were compared between ART and non-ART twins. Chi-squared test for categorical variables and Student’s t-test for continuous variables were used for the comparison. Generalized Estimating Equations was used to assess the likelihood of ‘any adverse neonatal outcome’ following ART treatment, with odds ratio, adjusted odds ratio (AOR) (adjusted for maternal age, parity, Indigenous status of mother, pre-pregnancy BMI, and smoking during pregnancy) and 95% confidence intervals (CI) presented. Due to high proportion of missing data BMI and smoking during pregnancy, a sensitivity analysis was conducted by excluding smoking or BMI in the adjustment. Weinberg’s differential rule was used to estimate monozygotic twin rate [12]. Data were analysed using Statistical Package for Social Sciences (SPSS) software, version 22 (SPSS, Inc., Chicago, IL, USA).

Table 3 shows the monozygotic and dizygotic rate among ART and non-ART twins. Of twins where sex is available for both babies, same-sex twins made up 55.2% of ART twins compared to 71.4% non-ART twins. According to Weinberg’s differential rule, there were 478 monozygotic ART twins and 6456 monozygotic non-ART twins. This represents a monozygotic twin rate of 2.0% for ART births and 1.1% for non-ART births (Table 3).

The current analysis showed that ART twins had significantly higher rates of adverse neonatal outcomes in terms of preterm birth, low birthweight, the need for resuscitation and admission to NICU/SCN, long hospital stay and birth by caesarean section. In addition, among liveborn twins, ART twins had 28% increased odds of having any adverse neonatal outcome (AOR 1.28, 95% CI 1.09–1.50), especially for opposite-sex ART twins (AOR 1.42, 95% CI 1.11–1.82).

We found that ART mothers had higher rates of antepartum haemorrhage, pregnancy-induced hypertension, and gestational diabetes compared with non-ART mothers. This is consistent with results from two other studies [4, 9]. These adverse outcomes are partially explained by the background of subfertility or infertility. Women experiencing infertility, whether or not they undertake ART, have higher rates of many adverse outcomes when compared to women conceiving spontaneously within 12 months of trying [13].

In agreement with other studies, we found that the rate of preterm birth is significantly higher among ART twins than non-ART twins [9]. There are a number of potential explanations for the increased risk of preterm birth in ART births including the underlying maternal characteristics such as subfertility or medical conditions causing subfertility, obesity, and short stature, and the ART treatment itself [14]. The increased risk of preterm birth among twins is also partially explained by early fetal loss in a higher order multiple pregnancy [15]. Pinborg and colleagues suggested that survivors of a vanishing fetal hearts/gestational sacs were more likely to be born preterm and with low birth weight [15].

Our results illustrated that the rate of low birthweight in ART twins is significantly higher than non-ART twins. This is consistent with findings in a previous systematic review which reported a 14% increase in the risk of low birthweight among ART twins compared to non-ART twins (RR 1.14, 95% CI 1.06–1.22) [16]. The increased risk of low birthweight births in ART twins can partially be explained by the higher preterm birth rate among ART twins compared with non-ART twins. However, in this study, as in previous reports, the higher rate of preterm birth alone does not explain the increased risk of low birthweight [16, 17]. Multiple pregnancies observed on the initial ultrasound is closely linked to the increased risk of low birthweight [18].

During the study period, the twin delivery rates following ART decreased from 24.5% in 2007 to 18.2% in 2011. This has paralleled the increase in the proportion of single embryo transfer in Australia from 63.7% in 2007 to 73.2% in 2011 [6]. An Australian study suggested that a voluntary policy of single embryo transfer introduced in 2002 had a significant impact to the fall in the proportion of ART multiple births [19]. Other studies further advocated that continuing the policy of single embryo transfer would prevent multiple pregnancies and improve overall maternal and neonatal outcomes following ART [20, 21]. Luke 2017 concluded that transferring high quality and fewer embryos is responsible for reducing the risk of multiple births from ART treatments and ultimately reducing the perinatal adverse outcomes [22].

Our findings show that for opposite-sex twins, ART twins had 42% increase in the likelihood of any adverse neonatal outcome compared to non-ART twins. Opposite-sex twins are all dizygotic twins which arise from the fertilisation of two separate ova by two separate sperm resulting in the formation of two separate zygotes in natural pregnancy, or from multiple embryo transfers in ART pregnancy. Virtually all dizygotic twins develop their own placenta and membranes so are dizygotic dichorionic diamniotic twins. Exceptional cases of monochorionic dizygotic twins have been reported, however, they are very rare [23]. The higher rate of any adverse outcome in ART twins is possibly related to the underlying infertility of the couples, the development of the embryo in the laboratory or the transfers of multiple embryos [24].

Interestingly, we found that the rate of any adverse neonatal outcome was higher among same-sex ART twins than same-sex non-ART twins, but it was not statistically significant. Same sex twins can be monozygotic or dizygotic twins, given that all monozygotic twins are same-sex twins and about half of dizygotic twins are of the same sex [23]. In natural pregnancy, monozygotic twins develop by splitting zygote from the fertilisation of a single ovum with a single sperm [25]. Subsequent placentation depends on the time of zygote splitting, with monozygotic dichorionic twins if splitting before day 3 and monozygotic monochorionic twins if splitting on day 3 or after. In ART pregnancy, monozygotic twins result from the splitting of the single transferred embryo. Since embryo transfers are virtually all on day 3 or after, monozygotic monochorionic twins are likely to develop [26]. However, we are unable to identify monozygotic twins from same-sex dizygotic twins and compare the neonatal outcomes between ART monozygotic twins and non-ART monozygotic twins.

Without genetic testing and details of the number of embryos transferred available, it is difficult to identify monozygotic twins. One way to estimate the rate of monozygotic twins is to use the sex of twin pairs by applying Weinberg’s differential rule [26]. Our data showed that the proportion of same-sex twins was lower among ART group (55.2%) than non-ART group (71.4%). This proportion is slightly higher than Pinborg and colleagues proportions of same-sex twins (50.8% among ART twins and 65.3% among non-ART twins) [27] but, similar to the Australian register [28]. Based on Weinberg’s differential rule, we estimated that among ART births, monozygotic twin rate was 2.0 and 1.1% among non-ART births. These estimates are higher than the monozygotic twin rates from a systematic review where the rate was 0.9% (95% CI: 0.8–0.9%) in ART twins compared to 0.4% (95% CI: 0.4–0.4) in naturally conceived twins [29].

The major strength of this study was the population based-design. The advantage of population-based studies rests on the inclusion of all patients in a given population and are therefore have less tendency to selection biases compared to the other types of observational studies [30].

Twin pregnancies following ART treatment are highly associated with multiple embryo transfers [31]. Unfortunately, the number of embryos transferred is not captured in the NPDC. We were unable to further investigate the ART twins by single or multiple embryo transfers. In addition, there were other limitations in this study. Apart from number of embryos transferred, other detailed type of ART treatment and procedures were not available in NPDC, such as fresh versus frozen embryo transfer, cleavage versus blastocyst transfers. Studies have demonstrated that the perinatal outcomes vary by fresh versus frozen embryo transfers, autologous versus donor treatment and cleavage versus blastocyst transfers [20, 21, 32]. The information on BMI and smoking during pregnancy was not stated for a large proportion of mothers (80.4% for BMI and 25.6% for smoking during pregnancy). This reflected that some jurisdictions did not have smoking status and or BMI in their routine data collection. The large proportion of mothers with missing data on BMI and smoking during pregnancy and the differential missing data between ART and non-ART mothers would have reduced the validity of the comparison and multivariate analysis.

This study using population cohort approach provided a high level of evidence where a randomized controlled trial is not feasible. The findings of this study strengthen the evidence on of higher adverse neonatal outcomes among ART twins than non-ART twins. These adverse outcomes are likely related to both the type of conception and the underlying infertility of the women. Women/couples accessing ART treatment should be fully informed of the risk of adverse outcome of twin pregnancies following ART treatment.

Acknowledgements

This research is based on data made available by AIHW. The authors acknowledge AIHW for funding the NPDC and midwives and neonatal nurses for collecting data for the NPDC.

Availability of data and materials

The data that support the findings of this study are available from the Australian Institute of Health and Welfare (AIHW) but restrictions apply to the availability of these data, which were used under license for the current study, and so are not publicly available. Data are however available from the authors upon reasonable request and with permission of AIHW.

Authors’ contributions

All authors have contributed to the conducting of this study. AW designed the study, prepared the data, drafted the manuscript, and approved the final manuscript as submitted. NS and FA carried out the initial analyses, drafted the manuscript and approved the final manuscript as submitted. KL, ZL and MU reviewed and revised the manuscript, and approved the final manuscript as submitted. ES conceptualised and designated the study, reviewed and revised the manuscript, and approved the final manuscript as submitted.

Ethics approval and consent to participate

Ethics approval for this study was granted by the Human Research Ethics Committee of the University of New South Wales (HREC 11024) and the Australian Institute of Health and Welfare Ethics Committee (EC 2011/1/5).

The dataset supporting the conclusion was pre-collected in non-identifiable format. Therefore, informed consent was waived by the ethics committee.

Consent for publication

Not applicable.

Competing interests

Alex Wang is a member of the editorial board (Associate Editor) of BMC Pregnancy and Childbirth.

Publisher’s Note

Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.

Open AccessThis article is distributed under the terms of the Creative Commons Attribution 4.0 International License (http://creativecommons.org/licenses/by/4.0/), which permits unrestricted use, distribution, and reproduction in any medium, provided you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons license, and indicate if changes were made. The Creative Commons Public Domain Dedication waiver (http://creativecommons.org/publicdomain/zero/1.0/) applies to the data made available in this article, unless otherwise stated.

Macaldowie A, Lee E, Chambers GM. Assisted reproductive technology in Australia and New Zealand 2013. Sydney: National Perinatal Epidemiology and Stastistics Unit, The University of New South Wales; 2015.Google Scholar

Luke B. Pregnancy and birth outcomes in couples with infertility with and without assisted reproductive technology: with an emphasis on US population-based studies. Am J Obstet Gynecol. 2017;217(3):270–81.View ArticlePubMedGoogle Scholar